NCBI PubMed NLM PubMed
Entrez PubMed Nucleotide Protein Genome Structure OMIM PMC Journals Books
 Search for
  Limits  Preview/Index  History  Clipboard  Details     
About Entrez

Text Version

Entrez PubMed
Overview
Help | FAQ
Tutorial
New/Noteworthy
E-Utilities

PubMed Services
Journals Database
MeSH Database
Single Citation Matcher
Batch Citation Matcher
Clinical Queries
LinkOut
Cubby

Related Resources
Order Documents
NLM Catalog
NLM Gateway
TOXNET
Consumer Health
Clinical Alerts
ClinicalTrials.gov
PubMed Central

 Show: 
Items 1 - 20 of 55
 
 of 3
Next  
1: Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D, Crawford ED. Related Articles, Links
Abstract Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.
N Engl J Med. 2004 Oct 7;351(15):1513-20.
PMID: 15470214 [PubMed - indexed for MEDLINE]
2: Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Theodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA; TAX 327 Investigators. Related Articles, Links
Abstract Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
N Engl J Med. 2004 Oct 7;351(15):1502-12.
PMID: 15470213 [PubMed - indexed for MEDLINE]
3: McDermott RS, Anderson PR, Greenberg RE, Milestone BN, Hudes GR. Related Articles, Links
Abstract Cranial nerve deficits in patients with metastatic prostate carcinoma: clinical features and treatment outcomes.
Cancer. 2004 Oct 1;101(7):1639-43.
PMID: 15468187 [PubMed - indexed for MEDLINE]
4: Poulos CK, Koch MO, Eble JN, Daggy JK, Cheng L. Related Articles, Links
Abstract Bladder neck invasion is an independent predictor of prostate-specific antigen recurrence.
Cancer. 2004 Oct 1;101(7):1563-8.
PMID: 15378493 [PubMed - indexed for MEDLINE]
5: Coard KC, Freeman VL. Related Articles, Links
Abstract Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West Indies.
Am J Clin Pathol. 2004 Sep;122(3):373-6.
PMID: 15362366 [PubMed - indexed for MEDLINE]
6: Janssen JA, Wildhagen MF, Ito K, Blijenberg BG, Van Schaik RH, Roobol MJ, Pols HA, Lamberts SW, Schroder FH. Related Articles, Links
Abstract Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.
J Clin Endocrinol Metab. 2004 Sep;89(9):4391-6.
PMID: 15356036 [PubMed - indexed for MEDLINE]
7: Spetz AC, Zetterlund EL, Varenhorst E, Hammar M. Related Articles, Links
Abstract Incidence and management of hot flashes in prostate cancer.
J Support Oncol. 2003 Nov-Dec;1(4):263-6, 269-70, 272-3; discussion 267-8, 271-2. Review.
PMID: 15334868 [PubMed - indexed for MEDLINE]
8: Hernandez J, Thompson IM. Related Articles, Links
Abstract Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker.
Cancer. 2004 Sep 1;101(5):894-904. Review.
PMID: 15329895 [PubMed - indexed for MEDLINE]
9: Chen G, Shukeir N, Potti A, Sircar K, Aprikian A, Goltzman D, Rabbani SA. Related Articles, Links
Abstract Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Cancer. 2004 Sep 15;101(6):1345-56.
PMID: 15316903 [PubMed - indexed for MEDLINE]
10: Korkmaz CG, Korkmaz KS, Manola J, Xi Z, Risberg B, Danielsen H, Kung J, Sellers WR, Loda M, Saatcioglu F. Related Articles, Links
Abstract Analysis of androgen regulated homeobox gene NKX3.1 during prostate carcinogenesis.
J Urol. 2004 Sep;172(3):1134-9.
PMID: 15311057 [PubMed - indexed for MEDLINE]
11: Zielie PJ, Mobley JA, Ebb RG, Jiang Z, Blute RD, Ho SM. Related Articles, Links
Abstract A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.
J Urol. 2004 Sep;172(3):1130-3.
PMID: 15311056 [PubMed - indexed for MEDLINE]
12: Schroder FH, Kurth KH, Fossa SD, Hoekstra W, Karthaus PP, Debois M, Collette L; Members of the European Organisation for the Research and Treatment of Cancer Genito-urinary Group. Related Articles, Links
Abstract Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study.
J Urol. 2004 Sep;172(3):923-7.
PMID: 15310999 [PubMed - indexed for MEDLINE]
13: Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Related Articles, Links
Abstract Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.
J Urol. 2004 Sep;172(3):910-4.
PMID: 15310996 [PubMed - indexed for MEDLINE]
14: Canto EI, Singh H, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Related Articles, Links
Abstract Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection.
J Urol. 2004 Sep;172(3):900-4.
PMID: 15310993 [PubMed - indexed for MEDLINE]
15: Bostwick DG, Hossain D, Qian J, Neumann RM, Yang P, Young RH, di Sant'agnese PA, Jones EC. Related Articles, Links
Abstract Phyllodes tumor of the prostate: long-term followup study of 23 cases.
J Urol. 2004 Sep;172(3):894-9.
PMID: 15310992 [PubMed - indexed for MEDLINE]
16: Kirkpatrick J. Related Articles, Links
Abstract Radical prostatectomy versus watchful waiting in early prostate cancer.
J Insur Med. 2002;34(2):131-2. Review.
PMID: 15305791 [PubMed - indexed for MEDLINE]
17: Freedland SJ, Aronson WJ, Kane CJ, Terris MK, Presti JC Jr, Trock B, Amling CL. Related Articles, Links
Abstract Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels.
Cancer. 2004 Aug 15;101(4):748-53.
PMID: 15305405 [PubMed - indexed for MEDLINE]
18: Ekici S, Cerwinka WH, Duncan R, Gomez P, Civantos F, Soloway MS, Lokeshwar VB. Related Articles, Links
Abstract Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
Int J Cancer. 2004 Oct 20;112(1):121-9.
PMID: 15305383 [PubMed - indexed for MEDLINE]
19: Nilsson S, Norlen BJ, Widmark A. Related Articles, Links
Abstract A systematic overview of radiation therapy effects in prostate cancer.
Acta Oncol. 2004;43(4):316-81. Review.
PMID: 15303499 [PubMed - indexed for MEDLINE]
20: Ross JS, Jennings TA, Nazeer T, Sheehan CE, Fisher HA, Kauffman RA, Anwar S, Kallakury BV. Related Articles, Links
Abstract Prognostic factors in prostate cancer.
Am J Clin Pathol. 2003 Dec;120 Suppl:S85-100. Review.
PMID: 15298146 [PubMed - indexed for MEDLINE]
Items 1 - 20 of 55
 
 of 3
Next  
 Show: